Search

Your search keyword '"Diergaarde, Brenda"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Diergaarde, Brenda" Remove constraint Author: "Diergaarde, Brenda" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
42 results on '"Diergaarde, Brenda"'

Search Results

1. Supplementary Figure S2 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

2. Supplementary Table S2 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

3. Supplementary Methods S2 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

5. Supplementary Table S5 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

6. Supplementary Figure S2 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

7. Supplementary Methods S1 from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

8. Data from Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

9. Abstract 3015: Soluble CD137 and risk of hepatocellular carcinoma: nested case-control studies in cohorts in Shanghai and Singapore

11. Data from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

12. Supplementary Figures from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

13. Data from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

14. Supplementary Text from Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

15. Supplementary Tables 1 - 4 from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

17. Supplemental Table 1 from History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

19. Data from History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

24. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

25. Abstract 1930: Unsupervised sub-cellular segmentation of complex tissue and cell samples using highly multiplexed imaging-derived a priori knowledge

26. Abstract 2260: Non-alcoholic fatty liver disease polygenic risk score and risk of hepatocellular carcinoma in an East Asian population

29. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

30. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

31. Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival

34. Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

35. Abstract 2011: The PI3K pathway is the most frequently mutated mitogenic pathway in HNSCC.

36. Abstract 1340: Identification of epidermal growth factor receptor (EGFR) polymorphisms that modify risk for squamous cell carcinoma of the head and neck (HNSCC).

41. Abstract LB-414: Variation in base excision repair genes and risk of smoking-related non-small cell lung cancer

42. Polymorphisms in Genes Involved in Sex Hormone Metabolism, Estrogen Plus Progestin Hormone Therapy Use, and Risk of Postmenopausal Breast Cancer

Catalog

Books, media, physical & digital resources